United Therapeutics Corporation (UTHR)
NASDAQ: UTHR · Real-Time Price · USD
545.96
+0.56 (0.10%)
At close: Jun 12, 2026, 4:00 PM EDT
547.11
+1.15 (0.21%)
After-hours: Jun 12, 2026, 6:36 PM EDT

United Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
23,17421,26515,81810,34412,8019,741
Market Cap Growth
60.37%34.43%52.93%-19.20%31.41%44.27%
Enterprise Value
19,70318,34512,8518,05010,7628,610
Last Close Price
545.96487.25352.84219.89278.09216.08
PE Ratio
20.1717.4914.3211.1018.5421.48
Forward PE
19.1617.1412.179.9313.5713.45
PEG Ratio
1.974.431.0213.470.740.74
PS Ratio
7.316.685.504.446.615.78
PB Ratio
3.903.002.451.732.672.46
P/FCF Ratio
22.7920.4314.6413.8419.2920.40
P/OCF Ratio
14.8213.6211.9210.5815.9516.28
EV/Sales Ratio
6.225.764.473.465.565.11
EV/EBITDA Ratio
12.7211.628.876.5010.4414.21
EV/EBIT Ratio
13.4912.299.336.7910.9915.49
EV/FCF Ratio
19.3817.6311.8910.7716.2218.04
Debt / Equity Ratio
-00.050.120.170.20
Debt / EBITDA Ratio
--0.210.560.781.32
Debt / FCF Ratio
--0.280.941.211.68
Net Debt / Equity Ratio
-0.36-0.41-0.46-0.38-0.42-0.29
Net Debt / EBITDA Ratio
-1.41-1.85-2.05-1.85-1.98-1.87
Net Debt / FCF Ratio
-2.12-2.81-2.75-3.07-3.07-2.37
Asset Turnover
0.430.420.400.350.350.34
Inventory Turnover
2.352.252.302.411.551.36
Quick Ratio
4.125.834.804.078.916.97
Current Ratio
4.796.605.254.419.857.61
Return on Equity (ROE)
19.81%19.71%19.23%18.27%16.61%12.94%
Return on Assets (ROA)
15.74%15.25%14.72%13.86%13.37%9.10%
Return on Invested Capital (ROIC)
26.92%27.82%26.71%25.80%24.82%15.75%
Return on Capital Employed (ROCE)
21.37%21.41%21.20%19.64%18.55%12.14%
Earnings Yield
5.56%5.72%6.98%9.01%5.39%4.66%
FCF Yield
4.39%4.89%6.83%7.23%5.18%4.90%
Buyback Yield / Dilution
1.40%1.24%2.41%-2.47%-2.54%-6.05%
Total Shareholder Return
1.40%1.24%2.41%-2.47%-2.54%-6.05%
SEC Filings: 10-K · 10-Q